Metronidazole cream

DRUG4 trials

Sponsors

LEO Pharma, University of Maryland, Baltimore, University of Auckland, New Zealand, Duke University

Conditions

BioequivalenceHemorrhoid PainHemorrhoidsRosaceaRosacea, Erythematotelangiectatic

Early Phase 1

Pharmacokinetics of Metronidazole Dermal Products

CompletedNCT03271983

University of Maryland, BaltimoreBioequivalence

Start: 2019-04-09End: 2019-11-03Updated: 2022-05-17

Phase 2

Topical Analgesia Post-Haemorrhoidectomy

CompletedNCT04276298

University of Auckland, New ZealandHemorrhoid Pain, Hemorrhoids

Start: 2020-09-01End: 2022-02-01Updated: 2022-05-18

Unknown Phase

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

CompletedNCT02602470

LEO PharmaRosacea

Start: 2015-01-08End: 2016-03-10Updated: 2020-04-01

Metronidazole SC Penetrance With Moisturizers

CompletedNCT06434519

Duke UniversityRosacea, Erythematotelangiectatic

Start: 2024-09-03End: 2025-11-04Updated: 2026-01-30

Related Papers

A Randomized Controlled Trial of Topical Analgesia Posthemorrhoidectomy (TAPH Trial)

Diseases of the Colon & Rectum2024-06-115 citations